Diabetes

Ninety percent of diabetes cases are type 2, which is a major cause of morbidity and mortality.

System involves a small sensor wire inserted below the skin’s surface to continuously measure and monitor glucose in adults with diabetes.

Officials with the FDA have approved FreeStyle Libre Flash Glucose Monitoring System (Abbot Diabetes Care Inc.), the first continuous glucose monitoring system for adult patients that reduces the need for fingerstick testing.

Biologics play a significant role in patient care, but because of the high cost of these medications, they may be inaccessible to patients and increase health care costs.

Two fixed-ratio combination insulin/glucagon-like peptide-1 receptor agonists have been approved by the FDA.

The FDA has approved Qtern tablets by AstraZeneca to improve glycemic control in adults with type 2 diabetes.

Top news of the day from across the health care landscape.

Reducing fat in the pancreas can normalize insulin production and reverse type 2 diabetes.

A compound in coffee increased insulin secretion up to 87% in mice.

Pharmacists need to understand natural health products so that they can counsel patients, answer questions, and advise patients about potential drug interactions.

Genome analysis revealed 16 new gene variants that increase the risk of type 2 diabetes and heart disease.

Top articles of the week from The American Journal of Pharmacy Benefits.

Altered balance of gut microbiota during the first weeks of life may result in type 1 diabetes.

Compound derived from olives increases insulin secretion.

Benzidine-based dyes commonly used in pharmaceuticals are also found in popular candy, which may lead to adverse health issues.

Women with polycystic ovary syndrome 4 times as likely to develop diabetes.

Lifestyle management plans for lowering blood pressure are also highlighted in the guidelines and include suggestions on weight loss, nutrition, and increased physical activity.

The risk of irregular and rapid heartbeat increased in type 1 diabetic patients who had renal complications and poor glycemic control.

A cocoa-derived compound improved the function of beta cells in diabetes patients.

Top articles of the week from The American Journal of Pharmacy Benefits.

Benefits of GLP-1 agonists may exceed diabetes and obesity treatment.

A look at the top stories in pharmacy last week.

Liraglutide (Victoza) may reduce the risk of cardiovascular events for patients with type 2 diabetes.

The American Diabetes Association recommends that patients have their blood pressure checked at every visit to their healthcare provider.

Researchers are continuing to pursue cost-effective ways to serve patients with diabetes efficiently.

Health care professionals interested in improving outcomes for patients who have diabetes may find an article published in the September issue of Current Diabetes Report interesting.

Patients with type 1 or type 2 diabetes may be at an increased risk of certain preventable conditions.

The guidelines provide a few updates to the pharmacologic management of the disease.

Top articles of the week from The American Journal of Pharmacy Benefits.

Aurobindo Pharma USA delivers a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes to ensure value to our customers and high quality medicines to health care professionals and patients throughout the United States.